Evidence map›Paper›PMID 41846815›Full record

ArticleJournal of pharmacy & bioallied sciences2025

Efficacy of Integrating Immunotherapy with Surgical Resection in Oral Squamous Cell Carcinoma: A Clinical Study.

Kala Bagavathy, Angshuman Saha, Maryada Sravani, Manrit Milina, Anish Nelson, Lavanya Haridas Pasalkar, B S Dayanithi

Abstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kala BagavathyDepartment of Oral and Maxillofacial Surgery, Rajas Dental College and Hospital, Tirunelveli, Tamil Nadu, India.
Angshuman SahaDepartment of Pathology, KPC Medical College and Hospital, Kolkata, West Bengal, India.
Maryada SravaniDepartment of ENT and Head and Neck Surgery, Mamata Academy of Medical Sciences, Hyderabad, Telangana, India.
Manrit MilinaIntern, Kalinga Institute of Dental Sciences, Kalinga Institute of Industrial Technology (Deemed to be University), Bhubaneswar, Odisha, India.
Anish NelsonDepartment of Oral and Maxillofacial Surgery, AB Shetty Memorial Institute of Dental Sciences, Nitte (Deemed to be University), Mangalore, Karnataka, India.
Lavanya Haridas PasalkarDepartment of Oral Medicine and Radiology, Dr D Y Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, DPU, Pune, Maharashtra, India.
B S DayanithiDepartment of Oral and Maxillofacial Surgery, Meenakshi Medical College and Research Institute, Meenakshi Academy of Higher Education Research, Chennai, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This research evaluates the efficacy of integrating immunotherapy with surgical resection in the treatment of "oral squamous cell carcinoma (OSCC)." By analyzing clinical outcomes, we aim to provide evidence for a combined therapeutic approach. Methods: A cohort of 120 OSCC patients was divided into two groups: surgical resection alone ( Results: Patients in the combined therapy group showed significantly improved three-year overall survival (78% vs. 62%) and reduced recurrence rates (15% vs. 28%). Quality-of-life scores were also higher in the immunotherapy group. Conclusion: Integrating immunotherapy with surgical resection improves clinical outcomes in OSCC, suggesting a promising direction for multimodal treatment strategies.

Indexed as

Clinical outcomesimmunotherapyOSCCrecurrence ratessurgical resection

Identifiers

PMID41846815
PMCPMC12991510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.